Published in Ann Rheum Dis on September 01, 1993
Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules. Ann Rheum Dis (2004) 0.93
A giant rheumatoid nodule. Clin Rheumatol (2004) 0.86
A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers. Ann Rheum Dis (1998) 0.85
Cutaneous nodules in patients with rheumatoid arthritis: a case report and review of literatures. Clin Rheumatol (2010) 0.78
MRI appearance of retrocalcaneal bursitis and rheumatoid nodule in a patient with rheumatoid arthritis. Clin Rheumatol (2005) 0.76
Dermacase. Rheumatoid nodules. Can Fam Physician (2005) 0.75
Rheumatoid nodules. Ann Rheum Dis (1994) 0.75
[Differential diagnosis of granulomatous diseases]. Z Rheumatol (2017) 0.75
A Variant of Rheumatoid Arthritis resembling Palindromic Rheumatism. Ann Rheum Dis (1949) 4.09
Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science (1983) 2.96
T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum (1985) 2.06
Methotrexate in rheumatoid arthritis. Arthritis Rheum (1988) 1.78
Rheumatoid nodules. Review of the spectrum of associated conditions and proposal of a new classification, with a report of four seronegative cases. Am J Med (1984) 1.66
The rheumatoid nodule. Arthritis Rheum (1990) 1.37
Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum (1988) 1.25
Immunological and immunohistochemical analysis of rheumatoid nodules. Ann Rheum Dis (1989) 1.22
Rheumatoid nodulosis: an unusual variant of rheumatoid disease. Arthritis Rheum (1975) 1.19
Necrobiosis lipoidica, granuloma annulare, and rheumatoid nodule. J Invest Dermatol (1960) 1.00
Benign rheumatoid nodules in a woman with chronic lymphocytic leukaemia and borderline lepromatous leprosy. Ann Rheum Dis (1993) 0.94
Benign rheumatoid nodules. Aust N Z J Med (1979) 0.88
Phenotypic markers of lymphocyte and mononuclear phagocyte activation within rheumatoid nodules. J Rheumatol (1990) 0.88
Rheumatoid vasculitis with worsening nodulosis. J Rheumatol (1990) 0.81
Rheumatoid arthritis. Curr Opin Immunol (1991) 0.81
T-cell receptor expression in patients with rheumatic diseases. Prog Histochem Cytochem (1992) 0.79
Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum (2001) 2.96
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis. Ann Rheum Dis (2004) 2.18
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis (2004) 2.15
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study. Ann Rheum Dis (2000) 1.79
Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. Ann Rheum Dis (2002) 1.76
Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum (2001) 1.70
Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity. Ann Rheum Dis (2000) 1.47
Tuberculin skin test versus interferon-gamma release assays for the diagnosis of tuberculosis infection. Acta Clin Belg (2014) 1.43
Etiological factors and underlying conditions in patients with leucocytoclastic vasculitis. Clin Exp Rheumatol (1997) 1.42
Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet (2000) 1.42
Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum (2000) 1.39
Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol (2000) 1.37
Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients. Clin Rheumatol (1999) 1.36
Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study. Ann Rheum Dis (2010) 1.34
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus. Ann Rheum Dis (2004) 1.32
Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis (2005) 1.31
Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease? Ann Rheum Dis (2003) 1.31
A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. Rheumatology (Oxford) (2002) 1.27
Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus. Ann Rheum Dis (2008) 1.19
The antiperinuclear factor. Clin Exp Rheumatol (1991) 1.18
Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol (1990) 1.16
The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum (2001) 1.15
Linkage of a polymorphic marker for the type III collagen gene (COL3A1) to atypical autosomal dominant Ehlers-Danlos syndrome type IV in a large Belgian pedigree. Hum Genet (1988) 1.13
Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha. Ann Rheum Dis (2001) 1.13
Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype. Ann Rheum Dis (2002) 1.11
Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor. Autoimmun Rev (2005) 1.10
CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease. Ann Rheum Dis (2004) 1.06
Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy. Ann Rheum Dis (2004) 1.06
Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis (2001) 1.05
The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications. Lupus (2005) 1.05
Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. Clin Exp Rheumatol (1999) 1.02
Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol (1993) 1.01
Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides. Rheumatology (Oxford) (2008) 1.00
Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease. Ann Rheum Dis (2004) 0.98
Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus. Ann Rheum Dis (2005) 0.97
Chemical agents and enzymes used for the extraction of gut lymphocytes influence flow cytometric detection of T cell surface markers. J Immunol Methods (2000) 0.97
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment. Ann Rheum Dis (2005) 0.96
Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease. Ann Rheum Dis (2002) 0.96
Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis (2003) 0.95
Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163. Ann Rheum Dis (2004) 0.95
Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy. Ann Rheum Dis (2001) 0.94
Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis. Ann Rheum Dis (2008) 0.93
The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome. Clin Exp Immunol (2001) 0.93
Tumour necrosis factor alpha independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules. Ann Rheum Dis (2004) 0.93
Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis. Ann Rheum Dis (2007) 0.92
Technical validation of cDNA based microarray as screening technique to identify candidate genes in synovial tissue biopsy specimens from patients with spondyloarthropathy. Ann Rheum Dis (2004) 0.92
Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis. Ann Rheum Dis (2008) 0.92
Focal up-regulation of E-cadherin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer-associated cell lineage. Am J Clin Pathol (2000) 0.92
Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis. J Rheumatol (1998) 0.91
Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis. Rheumatology (Oxford) (2007) 0.91
Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis. Scand J Gastroenterol (1998) 0.90
Churg-Strauss syndrome presenting as polymyositis. Clin Exp Rheumatol (1995) 0.89
Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis. J Pathol (2002) 0.88
Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex. Ann Rheum Dis (2000) 0.88
Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis. Rheumatology (Oxford) (2005) 0.88
Prediction of diagnosis in patients with early arthritis using a combined Kohonen mapping and instance-based evaluation criterion. Artif Intell Med (2004) 0.87
Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis. Ann Rheum Dis (2006) 0.87
Altered expression of alpha E beta 7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease. Acta Gastroenterol Belg (1998) 0.86
The history of injectable biomaterials and the biology of collagen. Aesthetic Plast Surg (1985) 0.85
A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers. Ann Rheum Dis (1998) 0.85
Sensitivity of the HEp-2000 substrate for the detection of anti-SSA/Ro60 antibodies. Clin Rheumatol (2000) 0.85
Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies. Ann Rheum Dis (2005) 0.84
Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alphaEbeta7 integrin. Clin Exp Rheumatol (2002) 0.84
Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint. Arthritis Rheum (2007) 0.83
CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients. Clin Exp Immunol (2005) 0.82
Interlaboratory variability of the antiperinuclear factor (APF) test for rheumatoid arthritis. Clin Exp Rheumatol (1993) 0.82
Case number 34: Relapse of polyarteritis nodosa presenting as isolated and localised lower limb periostitis. Ann Rheum Dis (2005) 0.82
History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis. Int J Immunopathol Pharmacol (2004) 0.82
Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo. Ann Rheum Dis (2007) 0.81
Altered gut transcriptome in spondyloarthropathy. Ann Rheum Dis (2006) 0.81
Broadening of the T cell receptor spectrum among rheumatoid arthritis synovial cell-lines in relation to disease duration. Clin Exp Rheumatol (2000) 0.81
Over-representation of construction-related occupations in male patients with systemic sclerosis. Ann Rheum Dis (2008) 0.81
Influence of the gut and cytokine patterns in spondyloarthropathy. Clin Exp Rheumatol (2002) 0.81
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip. Ann Rheum Dis (2006) 0.81
Case Number 29: Ochronosis: synovial histopathological characteristics. Ann Rheum Dis (2004) 0.79
Changes in antinuclear serology in patients with spondylarthropathy under sulphasalazine treatment. Br J Rheumatol (1993) 0.79
Review article: bone and joint diseases in inflammatory bowel disease. Aliment Pharmacol Ther (1998) 0.78
Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha. Ann Rheum Dis (2001) 0.78
Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis. J Immunol Methods (2012) 0.77
Ehlers-Danlos syndrome type I: a clinical and ultrastructural study of a family with reduced amounts of collagen type III. Br J Dermatol (1987) 0.77
Leflunomide and methotrexate combination therapy in daily clinical practice. Ann Rheum Dis (2006) 0.77
Work participation in patients with systemic sclerosis: a systematic review. Clin Exp Rheumatol (2014) 0.77
Klinefelter's syndrome and scleroderma. J Rheumatol (1989) 0.77
The pathophysiology of lupus erythematosus. Eur J Dermatol (1999) 0.76
Polyarteritis nodosa and the antiphospholipid syndrome. Clin Rheumatol (1996) 0.76
An optimized method for routine HLA-B27 screening using flow cytometry. Cytometry (1994) 0.76
Proinflammatory cytokine production and cell adhesion molecule expression compared in rheumatoid nodules and synovial membranes: comment on the article by Wikaningrum et al. Arthritis Rheum (1999) 0.75
Successful use of infliximab in a patient with treatment resistant spondyloarthropathy related uveitis. Ann Rheum Dis (2002) 0.75
Tenosynovitis with acute onset: unexpected giant cell tumour of the tendon sheath. Ann Rheum Dis (2002) 0.75
A red face in a lupus patient: thinking beyond lupus rash. Acta Clin Belg (2010) 0.75
Validation of a new screening strategy for anti-extractable nuclear antigen antibodies. Clin Exp Rheumatol (2010) 0.75
Polyarteritis nodosa mimicking polymyalgia rheumatica. Clin Rheumatol (1999) 0.75
Microscopic polyangiitis involving the breast. Acta Clin Belg (2011) 0.75
Unusual familial manifestation of Ehlers-Danlos syndrome. Prog Clin Biol Res (1982) 0.75
Classification models for disease: the effect of associations between markers on calculating the risk for disease by likelihood ratio products. Clin Exp Rheumatol (2009) 0.75
The immunological basis of inflammatory bowel disease. Acta Gastroenterol Belg (1997) 0.75
Re: Pulmonary arterial hypertension in connective tissue diseases. Rheumatology (Oxford) (2007) 0.75
Management of early inflammatory arthritis. Intervention with immunomodulatory agents: new pharmacological developments. Baillieres Clin Rheumatol (1992) 0.75
Second conference on spondylarthropathies and the gut. Clin Exp Rheumatol (1994) 0.75